Nishikawa T, Hasegawa K, Matsumoto K, Mori M, et al. Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial. J Clin Oncol 2023;41:2789-2799.
PMID: 36977309